VoxNeuro Announces Collaboration with the Canadian Armed Forces and Launch of Clinical Study Measuring Impact of Training-Related Sub-Concussive Exposure
VoxNeuro and CAF have partnered to study the cognitive effects following intense military training regimens designed to reflect a combat...
VoxNeuro Announces Collaboration with Boston University and Launch of Clinical Studies Focusing on Concussion and Alzheimer’s Disease
ORIGINAL PRESS RELEASE, Douglas Martin, AP News, September 7, 2022 VoxNeuro Inc. (“VoxNeuro” or the “Company”), a commercial-stage Software-as-a-Medical-Device (SaMD)...
VoxNeuro Announces Significant Milestones on its Mission to Become “The Brain Company”
The Forge client VoxNeuro Inc. has met three significant developments recently. The Software as a Medical Device (SaMD) brain health...